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Abstract
In order to resolve the location and activity of submicroscopic
viruses in living cells, viral proteins are often fused to fluorescent
proteins (FPs) and visualized by microscopy. In this study, we
describe the fusion of FPs to three proteins of pseudorabies
virus (PRV) that allowed imaging of capsids in living cells.
Included in this study are the first recombinant PRV strains
expressing FP–pUL25 fusions based on a design applied to
herpes simplex virus type 1 by Homa and colleagues. The
properties of each reporter virus were compared in both in vitro
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and in vivo infection models. PRV strains expressing FP–pUL25
and FP–pUL36 preserved wild-type properties better than
traditional FP–pUL35 isolates in assays of plaque size and
virulence in mice. The utility of these strains in studies of axon
transport, nuclear dynamics and viral particle composition are
documented.
Fusion of fluorescent proteins (FPs) to viral proteins has illuminated
numerous aspects of viral replication in the context of live-cell imaging.
Studies of herpesvirus infections have included FP fusions to all
components of the viral particle (envelope, tegument and capsid) and to
non-structural proteins. These recombinant viruses have proven
indispensable for understanding the dynamics of the herpesvirus particle
composition and host–pathogen interactions in cells (Smith & Banfield,
2006). In particular, FP fusions to the capsid have aided the study of the
entire course of the infection cycle, including: (i) capsid entry into the host
cell, (ii) transport of the capsid to the nucleus, (iii) intranuclear capsid
dynamics, and (iv) virion egress from host cells. While FPs have
revolutionized the field of virology, viruses encoding FPs are mutants that
may only approximate the behaviour of wild-type viruses. Although these
reporter viruses can yield intriguing new data, assuring that observations are
biologically relevant is best achieved by using reporter viruses that maintain
wild-type properties and replicating findings with different fusions when
possible.
VP26 (pUL35) was the first herpesvirus capsid protein fused to an FP and
remains the most common approach for capsid visualization (Desai &
Person, 1998; Frampton et al., 2010; Smith et al., 2001). The surface of
capsids is decorated with six copies of pUL35 per hexon (900 copies per
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capsid) (Wingfield et al., 1997; Zhou et al., 1995). This high copy number
results in bright fluorescence when pUL35 is fused to an FP. Additionally,
pUL35 is the only non-essential capsid protein; while deletion of the UL35
gene from herpes simplex virus (HSV)-1 or pseudorabies virus (PRV)
reduces propagation by approximately 1 log, fusion of GFP to the amino
terminus of pUL35 in either virus has no impact on virus propagation
kinetics (Desai & Person, 1998; Luxton et al., 2005). However, a more
recently described PRV GFP–pUL35 isolate propagated similarly to a
UL35-null virus and displayed reduced neuroinvasion and increased mean
time to death in a mouse infection model (Krautwald et al., 2008).
Unlike pUL35, pUL25 is an essential capsid component that is necessary for
stable genome encapsidation and capsid nuclear egress (McNab et al., 1998;
O’Hara et al., 2010). Capsid-bound pUL25 interfaces with hexons, triplexes,
portal, pUL17 and the pUL36 (VP1/2) large tegument protein (Coller et al.,
2007; Conway et al., 2010; Pasdeloup et al., 2009). Along with its binding
partner, pUL17, pUL25 forms a capsid-surface feature first identified on C
capsids referred to as a C-capsid-specific component; however, an
alternative name for this structure, the capsid-vertex-specific component
(CVSC), was suggested because this structure is now recognized to surround
the vertices of all capsid species (Toropova et al., 2011). The CVSC is
present at 60 copies per capsid (Newcomb et al., 2006; Toropova et al.,
2011; Trus et al., 2007). To tag HSV-1 pUL25, GFP was inserted in-frame
between two conserved coding regions (Cockrell et al., 2009). Despite the
multi-functionality of pUL25, the HSV-1 pUL25–GFP double in-frame
fusion grew with wild-type kinetics and was used to identify the precise
location of pUL25 on the capsid surface (Conway et al., 2010).
pUL36 is a large capsid-bound tegument protein that remains associated
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with the capsid after detergent extraction (Gibson & Roizman, 1972;
Newcomb & Brown, 2010; Wolfstein et al., 2006). In yeast two-hybrid
studies using HSV-1 or varicella-zoster virus proteins, pUL36 interacts with
three capsid proteins: pUL17, pUL25 and pUL18 (VP23; triplex) (Fossum et
al., 2009; Uetz et al., 2006). Additionally, pUL36 co-immunoprecipitates
with the major capsid protein pUL19 from infected cells, although pUL25 is
currently the only confirmed binding site for pUL36 in intact capsids
(Coller et al., 2007; McNabb & Courtney, 1992). pUL36 is associated with
herpesvirus capsids in virions and in the cytoplasm during both early and
late stages of infection, making the protein an effective extra-nuclear
capsid-associated reporter (Antinone & Smith, 2010; Gibson & Roizman,
1972; Granzow et al., 2005; Luxton et al., 2005; Newcomb & Brown, 2010).
Like pUL25, pUL36 is essential for viral propagation (Desai, 2000; Fuchs et
al., 2004; Knipe et al., 1981; Smith & Enquist, 1999). Viral propagation is
unaffected by fusion of an FP to the amino terminus of pUL36, which has
allowed for the observation of capsid movement in the absence of pUL35
(Antinone et al., 2006).
All viruses used in this study were derived from the infectious clone
pBecker3 with the exception of PRV151 and PRV152 and are summarized in
the Supplementary Table (available in JGV Online) (Demmin et al., 2001;
Smith et al., 2000; Smith & Enquist, 2000). FP fusions are noted with
letters: GFP (G), or red FPs mRFP1 (R) or mCherry (R*) are placed before
or after a gene name, indicating N- or C-terminal fusion, respectively, with
a slash indicating a double in-frame fusion. PRV encoding GFP or mRFP1
fused to pUL35 were described previously (Smith et al., 2001, 2004). The
UL25/G and UL25/R* fusions were designed based on a previously
described HSV-1 recombinant (Cockrell et al., 2009; Conway et al., 2010).
All reporter viruses attained wild-type titres when grown on pig kidney
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epithelial (PK15) cells (Supplementary Table). Additionally, a single-step
growth assay was performed on PK15 cells to compare the growth kinetics
of PRV-UL25/R*, PRV-R-UL35 and PRV-WT (Fig. 1a). No kinetic defect
was observed for either reporter virus in cultured cells.
View larger version
Fig. 1. . In vitro and in vivo infectivity of reporter PRV. (a) Single-
step growth curves comparing PRV derived from the unmodified
pBecker3 infectious clone (WT) to two recombinant reporter viruses
(R-UL35 and UL25/R*). Virus was harvested from adherent PK15
cells (solid lines) or infected cell supernatants (dashed lines) and titres were
determined by plaque assay. (b) Plaque diameters in Vero cells at 4 days p.i.
Diameters of individual plaques (dots) are expressed as a per cent of the mean
plaque diameter of unmodified virus (WT). RFP (R) and GFP (G) fusions are noted
based on insertion location before, after, or in the middle (noted with a slash) of the
viral gene. Error bars indicate SD of plaque sizes of each reporter virus. (c and d)
Virulence of reporter viruses in an intranasal model of infection in CD-1 mice. In (c),
three independent trials (T1, T2 and T3) of intranasal infection by one of two reporter
viruses are compared. In (d) all viruses in this study are compared. Each symbol
represents one mouse. Error bars indicate SD of the mean time to death for each trial.
For all panels, asterisks indicate statistically significant difference from WT (*P<0.05,
**P<0.01 and ***P<0.001) as determined by Tukey’s multiple comparison test.
Plaque diameters of reporter viruses were measured to assess cell–cell
spread of fluorescent viruses. Vero cells were infected in a six-well plate
with 60–250 p.f.u. per well and overlaid with media containing methocel to
restrict viral diffusion. Three days after infection, viable cells were stained
overnight with neutral red solution. Plates were scanned and diameters (in
pixels) were measured for all plaques. Plaques of PRV-R-UL35 (74 % WT)
and PRV-G-UL35 (84 % WT) were both smaller than PRV-WT (Fig. 1b),
consistent with observations made in PRV-Kaplan (Krautwald et al., 2008).
Although we did not attempt to repair the FP–UL35 viruses by deleting the
FP sequences, the similarity between different FP–UL35 fusions indicated
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that the plaque defect was reproducible and due to the addition of an FP to
pUL35. Plaque diameters of PRV-UL25/R* were similar to PRV-WT (97 %),
indicating that fusing UL25 to mCherry had little effect on the ability of the
virus to spread between cells in a confluent monolayer, although PRV-
UL25/G produced smaller plaques (87 %). All noted reductions in PRV-
Becker plaque sizes were minimal when compared with the attenuated PRV-
Bartha strain PRV152. FP fusions to either terminus of pUL36 or expression
of soluble GFP in PRV-Becker strains had negligible impacts in plaque size.
A mouse CD-1 intranasal inoculation model was used to examine virulence,
and allowed for comparisons with a previous study (Krautwald et al., 2008).
Initially, three groups of five mice each were infected with three
independent stocks of PRV-UL25/R* or PRV-R-UL35 (8–9×105 p.f.u. per
nostril) and recorded to determine time of death (Fig. 1c). Variability in
results obtained between replica stocks was not statistically significant.
Using this same method, both PRV-R-UL35 and PRV-G-UL35 displayed
reductions in virulence when compared with wild-type PRV (Fig. 1d),
consistent with a previous report, although these reductions were small
compared with the attenuated PRV-Bartha strain PRV152 (Krautwald et al.,
2008). In contrast, FP-fusions to pUL25 or pUL36 did not significantly
reduce virulence.
While maintenance of infectivity is an important consideration when
selecting a protein for FP-fusion, the usefulness of an FP-fusion is
dependent on its brightness and visibility over background. To assess
relative fluorescence emission intensity, extracellular viral particles were
isolated from infected PK15 cell supernatants, spotted onto coverslips and
imaged by fluorescence microscopy with appropriate filters (Fig. 2; see
Supplementary Methods, available in JGV Online). As expected,
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fluorescence emissions per particle were greatest with FP–pUL35 viruses.
This was most evident when the same FP was used for each fusion; PRV-G-
UL35 fluorescence was three- to fourfold higher than observed with PRV-
UL25/G, PRV-G-UL36 or PRV-UL36-G (Fig. 2b). Additionally, the
fluorescence intensity of extracellular viral particles from PRV-G-UL36,
PRV-UL36-G and PRV-UL25/G were similar, suggesting that pUL25 and
pUL36 are incorporated at 1 : 1 stoichiometry in extracellular particles,
which is consistent with pUL25 serving as a binding site for pUL36 on
capsids (Coller et al., 2007). Given that the CVSC is present at 60 copies per
capsid we can extrapolate that there are probably 60 copies of pUL36 per
PRV particle, which refines an earlier estimate of pUL36 incorporation in
HSV-1 that extrapolated <150 copies of pUL36 per virion (Conway et al.,
2010; Heine et al., 1974; Trus et al., 2007). The reported ratio of pUL25 : 
pUL35 copy number (60 : 900) was not reinforced based on the intensities
from virions carrying the respective FP fusions. Because the design of the
pUL25–GFP fusions allows for full occupancy on HSV-1 capsids (Conway
et al., 2010), fusion of GFP to pUL35 appears to reduce pUL35 occupancy
on capsid hexons. In agreement with this conclusion, the original GFP
fusion to pUL35 in HSV-1 was estimated to have only 300–400 copies of
GFP–pUL35 per capsid, which more closely agrees with the observed
threefold difference in particle intensity (P. Desai, personal
communication). The fluorescence intensities of individual viral particles
were accurately modelled by Gaussian distributions, indicating that FP-
fusions were incorporated into particles with normal variance. These trends
were also observed in red fluorescent particles (Fig. 2a), although the
difference in brightness between mRFP1 and mCherry (~25 %) prevented
direct stoichiometric comparison (Shaner et al., 2004).
7
View larger version
Fig. 2. . Characterization of fluorescence emission intensities
from individual extracellular viral particles. The brightness of
individual RFP-tagged (a) and GFP-tagged (b) viral particles
released from PK15 cells 18–20 h p.i. was measured by summing
the grey levels of all pixels from each diffraction-limited spot.
Individual particles were grouped into bins according to fluorescence
intensity and plotted as histograms (bin size = 10 000 grey levels for
RFP viruses and bin size = 50 000 grey levels for GFP viruses; histogram bars not
shown). Gaussian curves (coloured lines) were fit to histograms by non-linear
regression (R2 >0.95, for all samples except G-UL36, R2 = 0.88). Insets show mean
viral particle intensity with SD; bar graph colours correspond to plotted Gaussian
curves.
The localization of fluorescent signals was monitored in Vero cells that
were infected with RFP reporter viruses at an m.o.i. of 5 (Fig. 3). At 2 and 5
h post-infection (p.i.), static fluorescent puncta were frequently observed at
the nuclear membrane in PRV-R-UL35, PRV-UL25/R, PRV-R-UL36 and
PRV-UL36-R* infections, indicating that these proteins remained associated
with capsids after entering cells and docking at nuclear pores (not shown).
At 8 h p.i., small, rapidly moving nuclear puncta consistent with single de
novo assembled capsids were detected in cells infected with PRV-R-UL35
and PRV-UL25/R*, although movement of these particles may be faster
than movement noted in HSV-1-infected cells (Forest et al., 2005). Due to
the absence of pUL35 on procapsids and the low copy number of pUL25 on
procapsids, the rapidly moving particles were probably not associated with
the packaging of DNA (Sheaffer et al., 2001; Thurlow et al., 2005).
However, fusion of FPs to pUL25 and pUL35 can facilitate observation of
diverse processes associated with A, B and C capsid dynamics in the nucleus
(Gibson & Roizman, 1972; Toropova et al., 2011). At 12 h p.i., single puncta
remained predominant in PRV-UL25/R*-infected cells, but immobile
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aggregates (often referred to as assemblons; Ward et al., 1996) were present
in nuclei of PRV-R-UL35-infected cells. At 24 h p.i., similar large
aggregates in PRV-UL25/R*-infected cells were evident. Differential timing
of aggregate formation suggests that tagging pUL35 with an FP exacerbates
capsid aggregation in the nucleus.
View larger version
Fig. 3. . Images of Vero cells infected with reporter viruses. At
indicated times p.i., cells were imaged by wide-field fluorescence
microscopy. All exposures are 200 ms, except (i) and (j), which are
100 ms exposures. Level settings are held constant between viruses R-UL35 and
UL25/R* and between viruses R-UL36 and UL36-R* so that the apparent brightness of
each image documents the true relative brightness of each sample. Image dimensions
are 53 µm × 53 µm.
Prior to the onset of capsid nuclear egress, R-UL35 fluorescence was mostly
confined to the nucleus, while UL25/R* displayed additional diffuse
fluorescence in the cytoplasm. In contrast, fluorescent pUL36 was excluded
from the nucleoplasm. Localization to the nuclear rim was observed for both
termini of pUL36, although rims were apparent in PRV-UL36-R* cells at an
earlier time (8 h p.i.) than in PRV-R-UL36 (12 h p.i.). In both cases, nuclear
rim localization was no longer predominant by 24 h p.i. We are preparing a
study that examines VP1/2 nuclear activities in greater detail.
The retrograde transport velocity of pUL35–FP PRV in axons of primary
chick sensory neurons were indistinguishable from the pUL25/R* PRV
(Supplementary Fig. S1, available in JGV Online). During late stages of
infection with any of the FP-fusion PRV strains, capsid-like puncta were
observed moving in the cytoplasm in curvilinear trajectories in the
cytoplasm of Vero cells consistent with microtubule transport (data not
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shown) (Luxton et al., 2005).
Throughout this study, the pUL25/R* strain of PRV maintained wild-type
virus properties, while allowing observation of viral capsids throughout the
replication cycle. However, the R-pUL35 virus remains a useful reagent for
studies of cytoplasmic capsid dynamics, including studies of microtubule
transport. While G-pUL35 is the brightest tag, mutant viruses encoding FP–
pUL35 fusions had defects in cell–cell spread in culture and virulence in
mice, and nuclear capsids had an increased propensity to aggregate. In
contrast, pUL25 and pUL36 FP-fusions performed similarly to WT viruses
in assays of virulence and cell–cell spread, but the capsid tags are dimmer
than pUL35, and pUL36 tags do not allow analysis of viral particles in the
nucleus. Knowledge of the behaviour of these fluorescent reporters will be
instrumental for more detailed studies of the dynamics of the herpesvirus
infectious cycle.
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Fig. 1. .
In vitro and in vivo infectivity of reporter PRV. (a) Single-step growth curves
comparing PRV derived from the unmodified pBecker3 infectious clone (WT) to two
recombinant reporter viruses (R-UL35 and UL25/R*). Virus was harvested from
adherent PK15 cells (solid lines) or infected cell supernatants (dashed lines) and
titres were determined by plaque assay. (b) Plaque diameters in Vero cells at 4 days
p.i. Diameters of individual plaques (dots) are expressed as a per cent of the mean
plaque diameter of unmodified virus (WT). RFP (R) and GFP (G) fusions are noted
based on insertion location before, after, or in the middle (noted with a slash) of the
viral gene. Error bars indicate SD of plaque sizes of each reporter virus. (c and d)
Virulence of reporter viruses in an intranasal model of infection in CD-1 mice. In (c),
three independent trials (T1, T2 and T3) of intranasal infection by one of two reporter
viruses are compared. In (d) all viruses in this study are compared. Each symbol
represents one mouse. Error bars indicate SD of the mean time to death for each trial.
For all panels, asterisks indicate statistically significant difference from WT (*P<0.05,
16
**P<0.01 and ***P<0.001) as determined by Tukey’s multiple comparison test.
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Fig. 2. .
Characterization of fluorescence emission intensities from individual extracellular
viral particles. The brightness of individual RFP-tagged (a) and GFP-tagged (b) viral
particles released from PK15 cells 18–20 h p.i. was measured by summing the grey
18
levels of all pixels from each diffraction-limited spot. Individual particles were
grouped into bins according to fluorescence intensity and plotted as histograms (bin
size = 10 000 grey levels for RFP viruses and bin size = 50 000 grey levels for GFP
viruses; histogram bars not shown). Gaussian curves (coloured lines) were fit to
histograms by non-linear regression (R2 >0.95, for all samples except G-UL36, R2 = 
0.88). Insets show mean viral particle intensity with SD; bar graph colours correspond
to plotted Gaussian curves.
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Fig. 3. .
Images of Vero cells infected with reporter viruses. At indicated times p.i., cells were
imaged by wide-field fluorescence microscopy. All exposures are 200 ms, except (i)
and (j), which are 100 ms exposures. Level settings are held constant between
viruses R-UL35 and UL25/R* and between viruses R-UL36 and UL36-R* so that the
apparent brightness of each image documents the true relative brightness of each
sample. Image dimensions are 53 µm × 53 µm.
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